What early research suggests A handful of early studies have produced intriguing, but very preliminary, findings
513 Vedolizumab, a monoclonal antibody, is used primarily for the treatment of moderate-to-severe UC by targeting 47 integrins, blocking the homing pathway of colonic lymphocytes, and reducing the inflammatory response in the intestinal tract
Supports the Relief of Occasional Gastric Discomforts (e.g., occasional heartburn/indigestion, upset stomach, belching, burping, bloat, mild nausea)*
Related Reading: Tinsley Mortimers $35M Net Worth | It Girls of the Early 2000s: Where Are They Now
Aids nerve repair and gives your brain some protection as you recover